Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (251-260 of 773) with videos related to

Pageof 78
Sort By:
American Journal of Clinical Pathology|September 27, 2012
Laboratory persistence and clinical progression of small monoclonal abnormalitiesDavid L Murray, Justin L Seningen, Angela Dispenzieri, et al.
BMC Gastroenterology|November 5, 2016
Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES IIIAlberto Rubio-Tapia, Jonas F Ludvigsson, Rok Seon Choung, et al.
Basic Research in Cardiology|May 22, 2009
Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemiaMario Gössl, Jörg Herrmann, Hui Tang, et al.
The Journal of Applied Laboratory Medicine|May 26, 2023
Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined SignificanceKrasimira Rozenova, Maria Willrich, Melissa Snyder, et al.
Blood|October 22, 2024
Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detectionAlissa Visram, Dirk Larson, Aaron Norman, et al.
Nature Reviews. Disease Primers|July 21, 2017
Multiple myelomaShaji K Kumar, Vincent Rajkumar, Robert A Kyle, et al.
Oncotarget|August 6, 2016
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myelomaVijay Ramakrishnan, Marcus Gomez, Vivek Prasad, et al.
American Journal of Hematology|July 24, 2010
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cellsVijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, et al.
The New England Journal of Medicine|February 22, 2002
A long-term study of prognosis in monoclonal gammopathy of undetermined significanceRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Oncotarget|October 24, 2018
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myelomaUtkarsh Painuly, Vijay Ramakrishnan, Teresa Kimlinger, et al.
Pageof 78

Showing results (251-260 of 773) with videos related to

Sort By:
Pageof 78
American Journal of Clinical Pathology|September 27, 2012
Laboratory persistence and clinical progression of small monoclonal abnormalitiesDavid L Murray, Justin L Seningen, Angela Dispenzieri, et al.
BMC Gastroenterology|November 5, 2016
Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES IIIAlberto Rubio-Tapia, Jonas F Ludvigsson, Rok Seon Choung, et al.
Basic Research in Cardiology|May 22, 2009
Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemiaMario Gössl, Jörg Herrmann, Hui Tang, et al.
The Journal of Applied Laboratory Medicine|May 26, 2023
Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined SignificanceKrasimira Rozenova, Maria Willrich, Melissa Snyder, et al.
Blood|October 22, 2024
Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detectionAlissa Visram, Dirk Larson, Aaron Norman, et al.
Nature Reviews. Disease Primers|July 21, 2017
Multiple myelomaShaji K Kumar, Vincent Rajkumar, Robert A Kyle, et al.
Oncotarget|August 6, 2016
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myelomaVijay Ramakrishnan, Marcus Gomez, Vivek Prasad, et al.
American Journal of Hematology|July 24, 2010
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cellsVijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, et al.
The New England Journal of Medicine|February 22, 2002
A long-term study of prognosis in monoclonal gammopathy of undetermined significanceRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Oncotarget|October 24, 2018
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myelomaUtkarsh Painuly, Vijay Ramakrishnan, Teresa Kimlinger, et al.
Pageof 78